Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update

By Proactive Investors / June 13, 2023 / www.youtube.com / Article Link

Context Therapeutics CEO Marty Lehr joins Natalie Stoberman from the Proactive studios to discuss the latest data on clinical ...

Recent News

Gold stocks decline as metal price drops

June 29, 2026 / www.canadianminingreport.com

Tech takes a hit on South Korea semiconductor decline

June 29, 2026 / www.canadianminingreport.com

Gold stocks rise even as metal drops for second week

June 22, 2026 / www.canadianminingreport.com

Base outperform precious metals in slowdown from 2025 boom

June 22, 2026 / www.canadianminingreport.com

Mining stocks not looking expensive versus returns

June 15, 2026 / www.canadianminingreport.com

See all >